These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 4115470)
21. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain. Neff NH; Yang HY; Fuentes JA Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330 [No Abstract] [Full Text] [Related]
23. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid. Gomes B Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669 [No Abstract] [Full Text] [Related]
24. [Substrate specificity of monoamine oxidase from the brain and liver of the human fetus during antenatal ontogenesis]. Skorobogataia TG Ukr Biokhim Zh (1978); 1986; 58(2):81-3. PubMed ID: 3705207 [TBL] [Abstract][Full Text] [Related]
25. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase. Martin YC; Biel JH Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042 [No Abstract] [Full Text] [Related]
26. On the isolation and purification of structure-bound proteins. Monoamine oxidases of mitochondrial membranes. Akopyan ZI; Veryovkina IV; Levyant MI; Moskvitina TA; Gorkin VZ; Orekhovich VN Int J Protein Res; 1971; 3(3):121-9. PubMed ID: 5135302 [No Abstract] [Full Text] [Related]
27. Monoamine oxidases: versatility of catalytic properties and possible biological functions. Gorkin VZ Adv Pharmacol Chemother; 1973; 11():1-50. PubMed ID: 4201892 [No Abstract] [Full Text] [Related]
28. [The relationship between the activity of mitochondrial monoamine oxidase at different stages of its purification and the structure of the substrate]. Severina IS; Zhivotova NI Biokhimiia; 1973; 38(1):202-11. PubMed ID: 4778303 [No Abstract] [Full Text] [Related]
29. [On the chromatographic purification and some properties of rat mitochondrial monoamine oxidase]. Kliashtorin LB; Gridneva LI; Gorkin VZ Biokhimiia; 1966; 31(1):167-73. PubMed ID: 5982386 [No Abstract] [Full Text] [Related]
30. Enzymatic reduction of "biogenic" aldehydes in brain. Tabakoff B; Anderson R; Alivisatos SG Mol Pharmacol; 1973 Jul; 9(4):428-37. PubMed ID: 4146887 [No Abstract] [Full Text] [Related]
34. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues. Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193 [TBL] [Abstract][Full Text] [Related]
36. Turnover rates of monoamine oxidases: recovery of the irreversibly inhibited enzyme activity and the influence of isoproterenol. Planz G; Quiring K; Palm D Life Sci I; 1972 Feb; 11(3):147-60. PubMed ID: 4653196 [No Abstract] [Full Text] [Related]
37. The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives. Magyar K; Satory E; Meszaros Z Med Biol; 1974 Dec; 52(6):384-9. PubMed ID: 4444359 [No Abstract] [Full Text] [Related]
38. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors]. Severina IS Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599 [No Abstract] [Full Text] [Related]
39. Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B. Pons C; Dansette PM; Gregeois J; Homberg JC; Billett EE; Mansuy D Biochem Biophys Res Commun; 1996 Jan; 218(1):118-24. PubMed ID: 8573115 [TBL] [Abstract][Full Text] [Related]
40. [Kinetic study of monoamine oxidase activity of rat liver mitochondria]. Coq H; Baron C Bull Soc Chim Biol (Paris); 1968 Mar; 50(1):163-78. PubMed ID: 5639280 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]